D-0240-2026 Class II Ongoing

Recalled by SUN PHARMA /TARO — Hawthorne, NY

FDA drug recall D-0240-2026 was initiated by SUN PHARMA /TARO on Dec 9, 2025 and is designated Class II. Reason for recall: Failed Impurity/Degradation specifications: OOS results obtained at the 18-month timepoint The recall status is ongoing. Affected quantity: 17,664 units.

Recall details

Product Type
Drugs
Report Date
Dec 24, 2025
Initiation Date
Dec 9, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
17,664 units

Product description

Ciclopirox Shampoo, 1%, 120 mL, Rx only, Mfg by: Taro Pharmaceuticals Inc., Ontario, Canada; Dist. by: Taro Pharmaceuticals USA, Inc., NY 10532. NDC 51672-1351-08

Reason for recall

Failed Impurity/Degradation specifications: OOS results obtained at the 18-month timepoint

Distribution pattern

Nationwide within the United States

Code information

Lot #: AD37059, AD37060, AD37061, AD37062, AD37065, AD37066, AD37067, AD37068, expires: 1/31/2026.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0240-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0240-2026. Report a data issue: hello@regdatalab.com.